Drw Securities, LLC Biogen Inc. Transaction History

Drw Securities, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$212.02 - $267.71 $203,751 - $257,269	961 New	961 $207,000
Q3 2021 Nov 12, 2021	SELL	$282.99 - $369.05 $206,582 - $269,406	-730 Closed	0 $0
Q2 2021 Aug 12, 2021	SELL	$259.0 - $414.71 $10,619 - $17,003	-41 Reduced 5.32%	730 $253,000
Q1 2021 May 13, 2021	BUY	$242.95 - $284.63 $187,314 - $219,449	771 New	771 $216,000
Q2 2020 Aug 14, 2020	SELL	$258.66 - $342.55 $292,285 - $387,081	-1,130 Closed	0 $0
Q1 2020 May 13, 2020	BUY	$268.85 - $341.04 $303,800 - $385,375	1,130 New	1,130 $350,000
Q1 2018 May 14, 2018	SELL	$260.13 - $367.91 $767,903 - $1.09 Million	-2,952 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$307.64 - $344.58 $908,153 - $1.02 Million	2,952	2,952 $940,000

1,037

126M

1.13M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $23B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Drw Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Drw Securities, LLC with notifications on news.